Pruritus and restless legs syndrome (RLS) frequently affect patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD), impacting quality of life. Gabapentin alleviates these symptoms in hemodialysis (HD) patients but data are lacking for patients on the conservative pathway.
Please login or register first to view this content.